Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution.

PubWeight™: 1.89‹?› | Rank: Top 3%

🔗 View Article (PMID 11169942)

Published in Cancer on February 01, 2001

Authors

C A Portera 1, V Ho, S R Patel, K K Hunt, B W Feig, P M Respondek, A W Yasko, R S Benjamin, R E Pollock, P W Pisters

Author Affiliations

1: The University of Texas M. D. Anderson Cancer Center Multidisciplinary Sarcoma Center, Houston 77030-4009, USA.

Articles citing this

Alveolar soft-part sarcoma: a review and update. J Clin Pathol (2006) 2.14

Cediranib for metastatic alveolar soft part sarcoma. J Clin Oncol (2013) 1.99

Brain metastasis in bone and soft tissue cancers: a review of incidence, interventions, and outcomes. Sarcoma (2014) 1.10

Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases. World J Surg Oncol (2008) 1.05

Alveolar soft part sarcoma: a single-center 26-patient case series and review of the literature. Sarcoma (2012) 1.01

Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch (2009) 0.93

Spontaneous regression in alveolar soft part sarcoma: case report and literature review. World J Surg Oncol (2009) 0.88

Retrospective analysis of metastatic sarcoma patients. Oncol Lett (2011) 0.87

Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targets. PLoS One (2012) 0.85

Imaging features of primary and metastatic alveolar soft part sarcoma: single institute experience in 25 patients. Br J Radiol (2014) 0.84

Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to know. Cancer Imaging (2013) 0.84

Alveolar soft part sarcoma-radiologic patterns in children and adolescents. Pediatr Radiol (2013) 0.84

Primary alveolar soft part sarcoma of chest wall: a case report and review of the literature. MedGenMed (2006) 0.83

Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment? Neoplasia (2008) 0.83

Prominent Intracytoplasmic Crystals in Alveolar Soft Part Sarcoma (ASPS): An Aid in Cytological Diagnosis. J Clin Diagn Res (2014) 0.81

A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature. Int J Clin Oncol (2011) 0.81

Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies. Sarcoma (2012) 0.80

Alveolar soft-part sarcoma in the sacrum: a case report and review of the literature. Skeletal Radiol (2013) 0.80

Primary alveolar soft part sarcoma arising from the cerebellopontine angle. Childs Nerv Syst (2013) 0.79

Alveolar soft part sarcoma: a rare diagnosis. Indian J Dermatol (2013) 0.79

Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines. Clin Cancer Res (2015) 0.79

Alveolar soft-part sarcoma of the extremity: a case report. Hippokratia (2008) 0.79

Alveolar soft part sarcoma of the frontal calvarium and adjacent frontal lobe. J Pediatr Neurosci (2012) 0.78

Postoperative brain metastases in soft tissue sarcomas. Clin Exp Metastasis (2015) 0.78

Alveolar soft-part sarcoma in the left forearm with cardiac metastasis: A case report and literature review. Oncol Lett (2015) 0.77

Alveolar Soft Part Sarcoma-A Histological Surprise in a Male Patient who was Suspected to have Breast Cancer. J Clin Diagn Res (2013) 0.77

ASPL-TFE3 Oncoprotein Regulates Cell Cycle Progression and Induces Cellular Senescence by Up-Regulating p21. Neoplasia (2016) 0.77

A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib. Invest New Drugs (2016) 0.77

Alveolar soft part sarcoma metastasized to both the skull and the brain. J Korean Neurosurg Soc (2012) 0.76

Alveolar soft part sarcoma. BMJ Case Rep (2014) 0.75

Adult alveolar soft part sarcoma of the head and neck: a report of two cases and literature review. Case Rep Oncol Med (2014) 0.75

Clavicular and meningeal alveolar soft part sarcoma: An unusual case and literature review. J Orthop (2014) 0.75

Alveolar soft part sarcoma with brain metastases. Asian J Neurosurg (2017) 0.75

Rare Case Report of Alveolar Soft Part Sarcoma of the Orbit. Indian J Surg Oncol (2016) 0.75

Primary alveolar soft part sarcoma of uterine corpus: a case report with immunohistochemical, ultrastructural study and review of literature. World J Surg Oncol (2016) 0.75

Alveolar soft part sarcoma presenting as a breast metastasis in a patient with a history of thyroid cancer: a case report. Int J Clin Exp Pathol (2015) 0.75

Surgical management and outcome of spinal alveolar soft part sarcoma (ASPA): a case series of five patients and literature review. World J Surg Oncol (2017) 0.75

Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis. Ultrastruct Pathol (2014) 0.75

Identification of target genes of cediranib in alveolar soft part sarcoma using a gene microarray. Oncol Lett (2017) 0.75

Alveolar soft-part sarcoma of the mediastinum: A case report. SAGE Open Med Case Rep (2017) 0.75

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma. PLoS One (2017) 0.75

Articles by these authors

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol (1999) 7.59

Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg (1992) 3.40

Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol (1999) 3.18

Phytochrome E influences internode elongation and flowering time in Arabidopsis. Plant Cell (1998) 3.17

Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol (2004) 2.83

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg (1998) 2.81

Risk of dissemination of cancer to flap donor sites during immediate reconstructive surgery. Ann Plast Surg (1994) 2.76

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75

Indian public-private partnership for skilled birth-attendance. Lancet (2008) 2.65

Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56

Primary treatment of cystosarcoma phyllodes of the breast. Cancer (2000) 2.55

Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg (2006) 2.54

Phytochrome D acts in the shade-avoidance syndrome in Arabidopsis by controlling elongation growth and flowering time. Plant Physiol (1999) 2.42

Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol (2002) 2.42

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22

Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res (1997) 2.21

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10

Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience. J Urol (2001) 2.08

Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res (1997) 2.03

Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer (1992) 2.02

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg (1997) 2.00

Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol (2005) 1.93

Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol (1999) 1.92

Genetic and clinical predictors of warfarin dose requirements in African Americans. Clin Pharmacol Ther (2010) 1.88

Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol (2001) 1.88

New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol (2008) 1.87

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85

A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol (2001) 1.85

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 1.82

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol (2012) 1.81

Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am (1998) 1.77

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol (2001) 1.77

A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med (2000) 1.72

Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995. CMAJ (2000) 1.72

A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg (1997) 1.69

Hemangiopericytoma: a 20-year single-institution experience. Ann Surg Oncol (1998) 1.69

Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant (2010) 1.68

Clinical and radiological evidence to support superficial parotidectomy as the treatment of choice for chronic parotid sialadenitis: a retrospective study. Br J Oral Maxillofac Surg (2001) 1.68

Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67

Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg (1995) 1.66

Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol (2000) 1.65

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65

Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol (1990) 1.63

Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea. Thorax (2006) 1.62

Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery (2001) 1.60

Postoperative sore throat after routine oral surgery: influence of the presence of a pharyngeal pack. Br J Oral Maxillofac Surg (2002) 1.60

Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg (1999) 1.60

Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg (1990) 1.59

Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol (1998) 1.58

Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54

Providing skilled birth attendants and emergency obstetric care to the poor through partnership with private sector obstetricians in Gujarat, India. Bull World Health Organ (2009) 1.54

Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res (2000) 1.53

Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol (1999) 1.50

Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50

Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am (1999) 1.48

Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am (1999) 1.48

Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47

Comparison of forced-air warming and electric heating pad for maintenance of body temperature during total knee replacement. Anaesthesia (2006) 1.47

Adriamycin cardiomyopathy--risk factors. Cancer (1977) 1.46

Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res (2001) 1.46

Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection. Br J Dermatol (2012) 1.45

Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45

Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys (2001) 1.44

The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans. Clin Pharmacol Ther (2011) 1.43

Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol (2010) 1.42

Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol (2009) 1.41

Insulin secretion and action in patients with pancreatic cancer. Cancer (1991) 1.41

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg (1998) 1.40

What is a surgical oncologist? Ann Surg Oncol (1994) 1.40

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40